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Abstract
Introduction—Transposable element (TE) derived sequences comprise half of our genome and
DNA methylome, and are presumed densely methylated and inactive. Examination of the genome-
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wide DNA methylation status within 928 TE subfamilies in human embryonic and adult tissues
revealed unexpected tissue-specific and subfamily-specific hypomethylation signatures. Genes
proximal to tissue-specific hypomethylated TE sequences were enriched for functions important
for the tissue type and their expression correlated strongly with hypomethylation of the TEs. When
hypomethylated, these TE sequences gained tissue-specific enhancer marks including H3K4me1
and occupancy by p300, and a majority exhibited enhancer activity in reporter gene assays. Many
such TEs also harbored binding sites for transcription factors that are important for tissue-specific
functions and exhibited evidence for evolutionary selection. These data suggest that sequences
derived from TEs may be responsible for wiring tissue type-specific regulatory networks, and
have acquired tissue-specific epigenetic regulation.
A large portion of eukaryotic genomes is derived from transposable elements (TEs)1. TEs
have been described as parasitic or junk DNA. However, there is mounting evidence for
their evolutionary contribution to the wiring of gene regulatory networks2-7, a theory rooted
in Barbara McClintock’s discovery that TEs can control gene expression3,8,9. TEs contain
functional binding sites for transcription factors6,10,11; TE DNAs are presumed to be
methylated in somatic cells to suppress transposition and TE-mediated changes in gene
expression12-14. However, the extent to which DNA methylation silences TEs and how
DNA methylation-mediated silencing of TEs is reconciled with the known regulatory
function of TE sequences remain unexplored.
To construct TE DNA methylation profiles we assayed 29 human samples representing 11
cell types using two complementary DNA methylomics methods: MeDIP-seq and MRE-
seq15,16. Tissue and cell types included embryonic stem cells (ESC H1); fetal brain tissue
and primary neural progenitor cells (derived from cortex or ganglionic eminence regions);
primary adult breast epithelial cells (luminal epithelial cells, myoepithelial cells, and a
progenitor cell-enriched population); unfractionated peripheral blood mononuclear cells
(PBMC), and adult immune cells including CD4+ naïve, CD4+ memory, and CD8+ naïve
cells.
Mapping short-read data to TEs is difficult due to the high copy number of these elements.
Standard mapping often discard or mis-align high quality reads derived from TEs
(Supplementary Note). We developed a computational strategy termed Repeat Analysis
Pipeline (RAP) that allows mapping of reads derived from repetitive elements to one of
1,395 specific families of human repeats including 928 TE families (Supplementary Fig.
1-5, Note). RAP includes features of three previously published methods17-20 combined
with novel technical modifications (Methods).
As expected, sequences of the majority of TE families were methylated in all samples
examined. The total MeDIP-seq signal, which represents the proportion of individual TE
families that are methylated, correlated tightly with the total number of CpGs in that TE
family, consistent with the high level of DNA methylation in TEs (R2=0.95, Supplementary
Fig. 6-9). In contrast to TE families, total MeDIP-seq signal was 4.9% in promoter CpG
islands after normalizing for CpG content, consistent with the unmethylated status of
promoter CpG islands. Conversely, MRE-seq signal, which measures unmethylated DNA,
was 6.7-fold more enriched over promoter CpG islands than in TEs (Supplementary Fig.
6-9).
Strikingly, we found sequences of numerous TE families that were differentially methylated
in specific cell-types. Unsupervised clustering of samples based on TE methylation revealed
a clear relationship among tissue-types, indicating that TE methylation is a signature that
can distinguish tissue- or possibly cell-types (Fig. 1a, b). We identified 14 TE families with
significant (p<0.05, ANOVA) hypomethylation patterns in brain samples, 55 in breast
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samples, 13 in blood samples, and 13 in ESC (total 95 TE families, p<0.05, ANOVA). More
than 800 other families were consistently methylated across cell types from these 29 samples
(Supplementary Note). Most tissue-specific hypomethylated TEs belonged to the ERV/LTR
class (69/95), whereas 12 were DNA transposon families (Supplementary Table 1). These
findings are consistent with previous studies that have shown that LTR-elements participate
in regulation of mammalian genes3,21-24, and support the hypothesis that LTRs might play a
role in the epigenetic regulation of cell-type specific gene expression. For each TE family,
we identified individual copies that were uniquely mappable and were tissue-specifically
hypomethylated. The complete list of TE families and coordinates of individual elements are
provided at our website (Supplementary Note).
We next investigated the genomic distribution of members of TE families showing tissue-
specific hypomethylation. Their proximities to “known genes” were not different from being
expected by chance (Supplementary Fig. 10). However, genes near members of these TE
families were significantly enriched for functions specific to the tissue type in which they
were hypomethylated (Table 1 and Supplementary Table 2). For example, hypomethylation
of the UCON29 DNA transposon was restricted to fetal brain, and 11 of the 60 genes with a
nearby UCON29 element are involved in neuron development (p<6.6×10−23, binomial test).
Another brain-specific hypomethylated retroelement, LFSINE, was located near 19 out of 87
genes involved in telencephalon development (p<1.5×10−5, binomial test). Similarly, genes
associated with LTR12 and LTR77, two ERVs hypomethylated in immune cells, were
enriched for immune-related functions, including ‘antigen processing and presentation of
peptide or polysaccharide antigen via MHC class II’ (p<7.4×10−6, binomial test), and
‘oxidation reduction’ (p<3.7×10−6, binomial test). While antigen processing and
presentation is a known function of lymphocytes and other antigen-presenting hematopoietic
cells, the enrichment of genes in the oxidation-reduction process was interesting because T-
cell activation, differentiation and proliferation are sensitive to the redox potential25,26.
DNA hypomethylation has been associated with distal regulatory regions27. We next asked
if TE sequences with tissue-specific DNA hypomethylation possessed other tissue-specific
epigenetic signatures. We generated histone modification data (H3K4me1, H3K4me3,
H3K27me3, H3K36me3 and H3K9me3) from these same tissues, and collected p300
genome-wide locations from related tissues28 (Fig. 2). Sequences within hypomethylated TE
families displayed remarkably strong tissue-specific H3K4me1 signals. For example,
LTR77, a TE of the ERV class, had the lowest methylated (MeDIP-seq) signal and the
highest unmethylated (MRE-seq) signal in blood (Fig. 2a). When we applied RAP to
H3K4me3 and H3K4me1 ChIP-seq data from the same samples, we found much stronger
signals within the LTR77 family in T cells compared to the three other cell and tissue types
(Supplementary Fig. 11). Using data from CD8+ naïve cells, we identified a “histone
signature” for all 148 LTR77 copies along with a 3kb region flanking the LTR (Fig. 2b,c).
We observed a strong H3K4me1 peak over the LTR element itself, suggesting that at least
some LTR77 elements had this enhancer mark. The H3K4me3 peak detected 3kb
downstream suggested nearby promoter activities, potentially from genes regulated by
enhancers embedded in LTR77. LFSINE and UCON29 displayed H3K4me1 enrichment
specifically in fetal brain (Fig. 2f,g, and Supplementary Fig. 12). Moreover, LFSINE and
UCON29 both accumulate p300 binding signals in the neuroblastoma cell-line SK-N-SH,
but not in any non-neural cell lines including ESC, HepG2, or GM12878 (Fig. 2h,
Supplementary Fig. 12). Similarly, the T cell-specific hypomethylated TE LTR77
accumulated p300 binding signal in GM12878 (a lymphoblastoid cell-line), but not in any
other cell type (Fig. 2d). These results suggested that hypomethylated DNA sequences
derived from TEs might serve as tissue-specific enhancers.
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We next asked if any of these hypomethylated, enhancer-like sequences within TE might
contribute to tissue-specific gene expression. We selected candidate TEs that could be
uniquely mapped using our data. As a proof of principle, we focused on two putative target
genes: ERAP1, a gene in the generation of most HLA class I-binding peptides, and the glial
cell line-derived neurotrophic factor (GDNF) family receptor alpha-1 GFRA1, a
neurotrophic factor involved in the control of neuron survival and differentiation29 (Fig.
3a,d). A LTR77 element was detected 2kb upstream of an ERAP1 alternative transcription
start site. Our genome-wide data suggested that this element was hypomethylated in T-cells,
a prediction confirmed by locus-specific bisulfite-sequencing (Fig. 3b). In addition to
enhancer-like signature, NF-kB and Pol2 ChIP-seq peaks were observed in a lymphoblastoid
cell-line (GM12878), but not in a non-lymphoblastoid cell-line (HepG2). Consistently,
ERAP1 exhibited the highest expression in T-cells (Fig. 3c). This LTR77 element exhibited
modest enhancer activity in 293T, SK-N-SH, and GM12878 cells based on reporter assay
(Supplementary Fig. 13, LTR77-1). In the brain samples, GFRA1 appeared as a putative
target of an LFSINE element (Fig. 3d). We observed tissue-specific H3K4me1 marks and a
H3K4me3 mark in the promoter region in fetal brain, but not in T-cells (Fig. 3d).
Transcription factor binding motifs, such as that for SOX10, a regulator of neural crest and
glial cell development30,31, were identified in the hypomethylated LFSINE element
upstream of GFRA1. Consistent with the hypothesis that LFSINE is a tissue-specific
enhancer, GFRA1 was highly and specifically expressed in neuronal cells (Fig. 3f). This
element exhibited enhancer activity in 293T and SK-N-SH cells but not in GM12878
(Supplementary Fig. 13, LFSINE-1). Hypomethylation of these TEs did not appear to be a
result of increased expression of nearby genes, since the hypomethylation was not observed
for other TE families in the same genomic neighborhood (Fig 3a, d). Additional members of
the LTR77, LTR12, UCON29 and LFSINE subfamilies were validated and shown to exhibit
tissue-specific hypomethylation and associate with nearby tissue-specific gene expression
(Supplementary Fig. 14, 15). Of the 36 TE derived candidates for which we performed
reporter gene assay, 26 showed enhancer activities ranging from 5- to 1000-fold increase in
at least one of the three cell-lines tested (Supplementary Fig. 13). These hypomethylated TE
sequences have not been previously annotated as functional elements, but our results suggest
that they may influence tissue-specific gene expression.
We next examined the relationship between sequences of TEs, their epigenetic status, and
transcription factor binding. We analyzed histone modification and binding data of
transcription factors of two cell-lines (GM12878 and SK-N-SH) published by
ENCODE32,33. We focused on individual copies of two TE families that exhibited tissue-
specific hypomethylation in either blood (LTR77) or fetal brain (LFSINE). Consistent with
our previous findings, members of these two TE families enriched for enhancer marks in a
cell type-specific manner (Fig. 4) – LTR77 exhibited H3K4me1 mark and p300 binding in
GM12878, but not in SK-N-SH; LFSINE exhibited p300 binding in SK-N-SH, but they did
not enrich for H3K4me1 or p300 signal in GM12878. Binding sites of several transcription
factors were enriched in LTR77 and LFSINE and showed cell type specificity (Fig. 4). For
example, NF-kB binding overlapped specifically with LTR77 in GM12878; Rad21 bound
within LFSINE more than within LTR77; and Rad21bound within LFSINE more in SK-N-
SH than in GM12878 (Fig. 4). Not surprisingly, many TEs were predicted to contain a
sequence motif when scanned using position specific weight matrices of transcription factors
(Fig. 4). Having a motif was neither necessary nor sufficient for the actual binding, which
correlated strongly with cell type-specific enhancer mark. Taken together, ENCODE data
confirmed that sequences of specific TE families exhibited cell type-specific enhancer
signatures and cell type-specific transcription factor binding. Whether there is a causal
relationship between the TEs’ epigenetic mark and transcription factor binding awaits
further investigation.
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For decades, TEs have been deemed as parasitic DNA as a result of the impact of their
transposition in the genome34,35. Transposition of TEs may be deleterious when they disrupt
coding sequences or normal gene expression, resulting in human diseases36-38. Thus, it is
believed that cells have acquired epigenetic mechanisms to cope with TEs so that
transposon-derived sequences are completely methylated and transcriptionally silent in
somatic tissues14,39.
However, TE transpositions might provide diverse genetic material for natural selection,
which would contribute to the evolution of species-specific traits and population
biodiversity40,41. Many functional elements were born by “exaptation”, a process in which
DNAs of a transposon are co-opted to benefit the host42-44. TE insertions with regulatory
functions have been described in mammals4,5,7,45. A substantial proportion of constrained
non-coding sequences arose from TEs46,47, pointing to transposons as a driving force in the
evolution of regulation network. Some hypomethylated TE subfamilies identified here were
conserved based on their PhastCons and PhyloP scores, suggesting that this conservation
might be a consequence of selection (Supplementary Fig. 16, 17). While we do not know
how many TEs could have regulatory functions, previous reports indicate that 5% of TEs are
under evolutionary constraint46,47. TE sequences were incorporated in gene networks under
the control of transcription factors including TP536, OCT44,7, CTCF48, and MER20 was
reported to have contributed to the origin of pregnancy in placental mammals5. TE-derived
sequences can directly regulate expression. For example, ISL1 is regulated by a SINE
element49, and so is FGF8 in the forebrain50. In both cases, TEs provide distal enhancers
that help control expression of host genes, and their hypomethylation status in brain cells
was confirmed by our genome-wide data (Supplementary Fig. 14).
Our findings help to resolve the conflicting observations that TE sequences are globally
suppressed by epigenetic mechanisms, including DNA methylation, but that they can
mediate gene regulation in some instances. In this study, we challenge the general notion
that TEs are constitutively methylated by examining the extent to which TE methylation
differs between cell-types and the relationship between epigenetic silencing and TE
sequences’ potential to impact gene regulation. Epigenetic control of TEs may contribute to
developmental stage-specific, cell type-specific, and perhaps health condition-specific gene
regulation. Distal regulatory regions are methylated at low levels, display enhancer
chromatin marks, and are occupied by cell type-specific transcription factors27. Our results
suggest that some TE sequences match this profile of distal enhancers. With a few
exceptions51,52, majority of human TEs were fixed and no longer active. Sequences within
these TEs, however, could be adapted to serve as enhancers, and these sequences might be
the reason for their epigenetic regulation. The mechanisms through which DNA within TEs
is demethylated and obtains enhancer chromatin marks, and the relationship between TE-
derived enhancers and other regulatory elements remain to be elucidated. A recent report
demonstrated transposons on a human chromosome acquired activating histone
modifications and changed DNA methylation status in mouse cells53. In rodents, some
endogenous retroviruses function as species-specific enhancers in the placenta54. Therefore,
as a source of new regulatory elements, TEs’ regulatory potential could be controlled by
tissue- or cell type-specific epigenetic regulation. In our study, examination of DNA
methylation in four distinct tissue types showed that while sequences of many TE families
are globally hypermethylated, about 10% of TE families are hypomethylated in a tissue-
specific manner and gain distal enhancer signatures. Analysis of a more extensive panel of
tissues may reveal that a much larger portion of sequences derived from TEs may harbor
gene regulatory function.
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Online Methods
Further details for computational analyses are provided in the Supplementary Note.
1. Sample preparation
Blood—Buffy coats were obtained from the Stanford Blood Center (Palo Alto, CA). Blood
was drawn and processed on the same day. Peripheral Blood Mononuclear cells (PBMC)
were isolated by Histopaque 1077 (Sigma-Aldrich. Saint-Louis, MO) density gradient
centrifugation according to the manufacturer’s protocol. Further purification of CD4
memory, CD4 naïve, and CD8 naïve T lymphocytes was performed using a Robosep
instrument and isolation kits for each subpopulation as listed below (STEMCELL
Technologies, Vancouver, BC, Canada). Total PBMC were karyotyped (Molecular
Diagnostic Services Inc. San Diego, CA) and analyzed for cell cycle. PBMC and T cell
subpopulations were stained with antibodies and analyzed by FACS for purity. Cells were
aliquoted for DNA and RNA samples, and were washed in PBS. Cell pellets for RNA
samples were resuspended in 1 ml TRIzol reagent (Invitrogen, Carlsbad, CA), and frozen at
−80°C. Cell pellets for DNA samples were flash frozen in liquid nitrogen and stored at
−80°C. Reagents and Antibodies:
Anti-CD3 TRI-COLOR, Invitrogen
Anti-CD4 PE, BD Biosciences
Anti-CD8 FITC, BD Biosciences
Anti-CD4 TRI-COLOR, Invitrogen
Anti-CD45RO PE, Invitrogen
Anti-CD45RA FITC, BD Biosciences
Anti-CD8 TRI-COLOR, Invitrogen
EasySep® Human Memory CD4 T Cell Enrichment Kit,
EasySep® Human Naive CD4+ T Cell Enrichment Kit,
Custom Human Naïve CD8 T cell Enrichment Kit, STEMCELL Technologies
Breast—Breast tissues were obtained from disease-free pre-menopausal women
undergoing reduction mammoplasty in accordance with institutionally approved IRB
protocol # 10-01563 (previously CHR # 8759-34462-01). All tissues were obtained as de-
identified samples and linked only with minimal dataset (age, ethnicity and in some cases
parity/gravidity). Tissue was dissociated mechanically and enzymatically, as previously
described56. Briefly, tissue was minced and dissociated in RPMI 1640 with L-glutamine and
25mm HEPES (Fisher, cat # MT10041CV) supplemented with 10% fetal bovine serum (JR
Scientific, Inc, cat # 43603), 100 units/ml penicillin, 100μg/ml streptomycin sulfate, 0.25μg/
ml fungizone, gentamycin (Lonza, Cat # CC4081G), 200U/ml collagenase 2 (Worthington,
cat # CLS-2) and 100U/ml hyaluronidase (Sigma-Aldrich, cat # H3506-SG) at 37°C for 16h.
The cell suspension was centrifuged at 1,400rpm for 10min followed by a wash with RPMI
1640/10% FBS. Clusters enriched in epithelial cells (referred to as organoids) were
recovered after serial filtration through a 150-μm nylon mesh (Fisher, cat # NC9445658),
and a 40-μm nylon mesh (Fisher, cat # NC9860187). The final filtrate contained primarily
mammary stromal cells (fibroblasts, immune cells and endothelial cells) and some single
epithelial cells. Following centrifugation at 1,200rpm for 5min, the epithelial organoids and
filtrate were frozen for long-term storage. The day of cell sorting, epithelial organoids were
thawed out and further digested with 0.5g/L 0.05% trypsin-EDTA and dispase-DNAse I
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(STEMCELL Technologies, cats # 7913 and # 7900, respectively). Generation of single cell
suspensions was monitored visually. Single cell suspensions were filtered through a 40-μm
cell strainer (Fisher, cat # 087711), spun down and allowed to “regenerate” in MEGM
medium (Lonza) supplemented with 2% fetal calf serum for 60-90min at 37°C. This
“regeneration” step enables quenching of trypsin and re-expression of the cell surface
markers prior to staining as their extra cellular domain had been cleaved by trypsin.
The single cell suspension obtained as described above was stained for cell sorting with
three human-specific primary antibodies, anti-CD10 labeled with PE-Cy7 (BD Biosciences,
cat # 341092) to isolate myoepithelial cells, anti-CD227/MUC1 labeled with FITC (BD
Biosciences cat # 559774) to isolate luminal epithelial cells or anti-CD73 labeled with PE
(BD Biosciences, cat # 550257) to isolate a stem cell-enriched cell population, and with
biotinylated antibodies for lineage markers, anti-CD2, CD3, CD16, CD64 (BD Biosciences,
cat # 555325, 555338, 555405 and 555526), CD31 (Invitrogen, cat # MHCD3115), CD45,
CD140b (BioLegend, cat #s 304003 and 323604) to specifically remove hematopoietic,
endothelial and leukocyte lineage cells, respectively, by negative selection. Sequential
incubation with primary antibodies was performed for 20min at room temperature in PBS
with 1% bovine serum albumin (BSA), followed by washing in PBS with 1% BSA.
Biotinylated primary antibodies were revealed with an anti-human secondary antibody
labeled with streptavidin-Pacific Blue conjugate (Invitrogen, cat # S11222). After
incubation, cells were washed once in PBS with 1% BSA and cell sorting was performed
using a FACSAria II cell sorter (BD Biosciences).
Fetal Brain—Post-mortem human fetal neural tissues were obtained from a case of twin
non-syndrome fetuses whose death was attributed to environmental/placental etiology.
Tissues were obtained with appropriate patient consent according to Partner’s Healthcare/
Brigham and Women’s Hospital IRB guidelines (Protocol #2010P001144). All samples and
tissues were de-identified and linked only with minimal dataset (age, gender, brain location).
Fetal brain tissue and fetal neural progenitor cells were derived from manually dissected
regions of the brain (telencephalon), specifically the neocortex (pallium; GSM666914,
GSM669615, GSM669610, GSM669612) and ganglionic eminences (subpallium;
GSM669611, GSM669613). The tissues were minced and dissociated by combination of
mechanical agitation (gentleMACS device) during enzymatic treatment with papain
according to manufacturer’s protocol (Miltenyi Biotec, Neural tissue dissociation kit
#130-092-628). Cell suspensions were then washed twice in DMEM and plated at low
density in human NeuroCult NS-A media (Stem cell technology # 05751) supplemented
with heparin, EGF (20ng/ml) and FGF (10ng/ml) in ultra low attachment cell culture flasks
(Corning #3814).
ESC H1—Data were obtained from a previous publication15.
2. High-throughput sequencing assays
All assays were performed as part of the NIH Roadmap Epigenomics Mapping Centers’
repository for human reference epigenome atlas57. Experiments were performed under the
guidelines of Roadmap Epigenomics project (http://www.roadmapepigenomics.org/
protocols). Specifically, MeDIP-seq and MRE-seq were performed as previously
described16. ChIP-seq was performed as described in 58. All data have been submitted to
NCBI (Supplementary Table 3).
3. Bisulfite validation
Total genomic DNA underwent bisulfite conversion following an established protocol59
with modification of: 95 °C for 1 min, 50 °C for 59 min for a total of 16 cycles. Regions of
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interest were amplified with PCR primers (see below) and were subsequently cloned using
pCR2.1/TOPO (Invitrogen). Individual bacterial colonies were subjected to PCR using
vector-specific primers and sequenced using an ABI 3700 automated DNA sequencer. The
data were analyzed with online software BISMA60. Result is summarized in Supplementary
Fig. 13. Genomic locations of candidates and primer information are summarized in
Supplementary Table 4.
4. Reporter gene assay
TE candidates were amplified from genomic DNA using Pfu-polymerase (Agilent) and
primers containing KpnI- or BglII- restriction sites. PCR products were gel-purified using
Qiagen Gel purification kit, and then digested by the corresponding restriction enzymes
(NEB). The digested PCR products were cloned into the pGL4.23[luc2/minP]-vector
(Promega, E8411) using T4-ligase(NEB) and transformed into chemical competent DH5α-
cells. The positive clones were verified by enzyme digestion and sequencing. 800 ng of
reporter plasmid (or empty pGL4.23[luc2/minP]-vector control) were transfected into 3
different cell lines, 293T, GM12878, and SK-N-SH_RA which were differentiated with 6
μM of retinoic acid for 48 hours from SK-N-SH cells, using X-tremeGENE (Roche) in
triplicate. In order to normalize the transfection, 200 ng of renilla luciferase plasmid driven
by a TK promoter were co-transfected. The luciferase activity was measured after 48 hours,
and normalized by the relative renilla control. Genomic locations of candidates and primer
information are summarized in Supplementary Table 5.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Clustering of TE families based on their DNA methylation profile reveals tissue
specificity
TE families (rows) were clustered based on their MeDIP-seq (a) or MRE-seq (b) enrichment
values across 29 samples (see Online Methods). The samples (columns) were clustered into
four major groups, which were consistent with their tissue types: ESC H1 (gray), Brain
(orange), Breast (blue), and Blood (purple). The vertical bar on the right side of the heat-
map represents TE classes: LTR (blue), DNA transposon (purple), SINE (orange), and LINE
(black). The corresponding methylation enrichment values are represented as horizontal bar
with varying color gradients at the bottom of each panel.
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Figure 2. Tissue-specific enhancer signatures of LTR77 and LFSINE
LTR77 (a-d) and LFSINE (e-h) are specifically hypomethylated in blood samples and brain
samples, respectively. (a) Boxplots of MeDIP-seq and MRE-seq enrichment scores of
LTR77 in multiple cell/tissue types. (b) Histone modification signatures of LTR77 in CD8+
Naïve cells. (c) Comparison of H3K4me1 signal of LTR77 between fetal brain sample and
CD8+ Naïve cells. (d) p300 binding signal on LTR77 in four cell lines. (e) Boxplots of
MeDIP-seq and MRE-seq enrichment scores of LFSINE in multiple cell/tissue types. (f)
Histone modification signatures of LFSINE in fetal brain sample. (g) Comparison of
H3K4me1 signal of LFSINE between fetal brain sample and CD8+ Naïve cells. (h) p300
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binding signal on LFSINE in four cell lines. Signals of different histone modification or
p300 binding for each genomic copy of the TE family including 3kb upstream and
downstream flanking regions were averaged in 5bp tiling windows. Error bar represents 1
standard deviation.
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Figure 3. Tissue-specific hypomethylated TEs correlate with gene expression
(a) Genome Browser view of an LTR77 element upstream of the ERAP1 gene. Displayed
tracks include: DNA methylation (MeDIP-seq) for human ESC H1, breast, brain and blood
samples; histone modification (H3K4me1 and H3K4me3) tracks for a CD8 naïve sample
and a fetal brain cell sample; transcription factor binding tracks (ENCODE) for NFkB, Pol2,
and TCF12 in three cell lines; gene annotation and RepeatMasker. (b) Bisulfite sequencing
validation of DNA methylation status of the LTR77 element (5 CpG sites) in human ESC
H1, breast, brain and blood samples. Black circle represents methylated CpG sites and white
circle represents unmethylated CpG sites. (c) Boxplots of expression levels of ERAP1 in 4
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different tissues. (d) Genome Browser view of an LFSINE element upstream of the GFRA1
gene. Displayed tracks include: DNA methylation (MeDIP-seq) for human ESC H1, breast,
brain, and blood samples; histone modification (H3K4me3 and H3K4me1) tracks for a fetal
brain sample and a CD8+ naïve cell sample; gene annotation and RepeatMasker. (e)
Bisulfite sequencing validation of DNA methylation status of the LFSINE element (4 CpG
sites) in human ESC H1, breast, brain, and blood samples. (f) Boxplots of expression levels
of GFRA1 in 4 different tissues.
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Figure 4. Correlation between cell type-specific enhancer marks, binding of transcription
factors, and sequence motifs
Histone modification, transcription factor binding, and sequence motif prediction data were
displayed for individual genomic copies of LTR77 and LFSINE. Each row represents one
element. Data were obtained from UCSC ENCODE portal33. For H3K4me1 histone
modification and p300 ChIP-seq data, RPKM values at 50bp resolution were plotted for a
10kb region centered on the TE copy. For transcription factor binding data, a red tick
indicates that the TE copy overlaps with a peak predicted using ChIP-seq data of the given
transcription factor in the given cell type. For sequence motif data, each TE copy was scored
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using position specific weight matrix of the given transcription factor. A blue tick indicates
log-transformed e-value of observing a sequence motif by chance.
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Table 1
GO enrichment of genes associated with hypomethylated TEs.
TE GO BiologicalProcess P-Value FDR
Gene
Hits
Fold
Enrichment
LFSINE
Telencephalon
development 1.49E-05 2.74E-03 19/87 3.55
Pallium development 9.35E-05 1.24E-02 12/56 3.48
Neuron migration 1.50E-04 1.79E-02 16/69 3.77
UCON29
Generation of neurons 6.6031E-23 3.6419E-20 11/656 4.9126
Neuron differentiation 3.3780E-22 1.4247E-19 10/500 5.8593
Neuron recognition 5.01E-5 4.49E-2 5/23 11.04
LTR12
Oxidation reduction 3.73E-06 2.67E-02 17/647 2.24
Antigen processing and
presentation of peptide
via MHC class II
7.40E-06 2.65E-02 2/20 8.53
LTR77
Homophilic cell
adhesion 7.0555E-7 5.0588E-3 10/105 11.70
Cell-cell adhesion 4.5389E-6 1.6272E-2 12/266 5.55
Genomic coordinates of individual TE copies of the TE families were used as input for GREAT analysis55. Each gene was assigned a basal
regulatory domain of 5kb upstream and 1kb downstream of the TSS (regardless of other nearby genes). The gene regulatory domain was extended
in both directions to the nearest gene’s basal domain but no more than a maximum of 1Mb extension in one direction. GO enrichment, p-values and
FDR values were computed by GREAT.
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Experiment Sample GEO ID
MeDIP-seq
H1Es Batch1 GSM543016
H1Es Batch2 GSM456941
Breast Luminal Epithelial Cells RM066 GSM613856
Breast Luminal Epithelial Cells RM070 GSM613843
Breast Luminal Epithelial Cells RM071 GSM613852
Breast MyoEpithelial Cells RM066 GSM613857
Breast MyoEpithelial Cells RM070 GSM613846
Breast MyoEpithelial Cells RM071 GSM613850
Breast Stem Cells RM066 GSM613859
Breast Stem Cells RM070 GSM613847
Breast Stem Cells RM071 GSM613853
CD4 Memory Primary Cells TC003 GSM613862
CD4 Memory Primary Cells TC007 GSM613914
CD4 Memory Primary Cells TC009 GSM669608
CD4 Naive Primary Cells TC003 GSM543025
CD4 Naive Primary Cells TC007 GSM613913
CD4 Naive Primary Cells TC009 GSM669607
CD8 Naive Primary Cells TC003 GSM543027
CD8 Naive Primary Cells TC007 GSM613917
CD8 Naive Primary Cells TC009 GSM669609
Fetal Brain HuFNSC01 GSM669614
Fetal Brain HuFNSC02 GSM669615
Neurosphere Cultured Cells, Cortex Derived HuFNSC01 GSM669610
Neurosphere Cultured Cells, Cortex Derived HuFNSC02 GSM669612
Neurosphere Cultured Cells, Ganglionic Eminence Derived HuFNSC01 GSM669611
Neurosphere Cultured Cells, Ganglionic Eminence Derived HuFNSC02 GSM669613
Peripheral Blood Mononuclear Primary Cells TC03 GSM543023
Peripheral Blood Mononuclear Primary Cells TC007 GSM613911
Peripheral Blood Mononuclear Primary Cells TC009 GSM669606
MRE-seq
H1Es Batch1 GSM428286
H1Es Batch2 GSM450236
Breast Luminal Epithelial Cells RM066 GSM613833
Breast Luminal Epithelial Cells RM070 GSM613818
Breast Luminal Epithelial Cells RM071 GSM613826
Breast MyoEpithelial Cells RM066 GSM613834
Breast MyoEpithelial Cells RM070 GSM613821
Breast MyoEpithelial Cells RM071 GSM613908
Breast Stem Cells RM066 GSM613837
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Experiment Sample GEO ID
Breast Stem Cells RM070 GSM613907
Breast Stem Cells RM071 GSM613829
CD4 Memory Primary Cells TC003 GSM613842
CD4 Memory Primary Cells TC007 GSM613903
CD4 Memory Primary Cells TC009 GSM669599
CD4 Naive Primary Cells TC003 GSM543011
CD4 Naive Primary Cells TC007 GSM613901
CD4 Naive Primary Cells TC009 GSM613920
CD8 Naive Primary Cells TC003 GSM543013
CD8 Naive Primary Cells TC007 GSM613905
CD8 Naive Primary Cells TC009 GSM613923
Fetal Brain HuFNSC01 GSM669604
Fetal Brain HuFNSC02 GSM669605
Neurosphere Cultured Cells, Cortex Derived HuFNSC01 GSM669600
Neurosphere Cultured Cells, Cortex Derived HuFNSC02 GSM669602
Neurosphere Cultured Cells, Ganglionic Eminence Derived HuFNSC01 GSM669601
Neurosphere Cultured Cells, Ganglionic Eminence Derived HuFNSC02 GSM669603
Peripheral Blood Mononuclear Primary Cells TC03 GSM543009
Peripheral Blood Mononuclear Primary Cells TC007 GSM613898
Peripheral Blood Mononuclear Primary Cells TC009 GSM613919
Histone
ChIP-seq
CD8 Naive Primary Cells TC001 H3K4me1 GSM613814
CD8 Naive Primary Cells TC001 H3K4me3 GSM613811
CD8 Naive Primary Cells TC001 H3K36me3 GSM669593
CD8 Naive Primary Cells TC001 H3K27me3 GSM613815
CD8 Naive Primary Cells TC001 H3K9me3 GSM613812
Fetal Brain HuFNSC01 H3K4me1 GSM806942
Fetal Brain HuFNSC01 H3K4me3 GSM806943
Fetal Brain HuFNSC01 H3K36me3 GSM806946
Fetal Brain HuFNSC01 H3K27me3 GSM806945
Fetal Brain HuFNSC01 H3K9me3 GSM806944
p300
(ENCODE/
HAIB)
GM12878 rep1 GSM803387
GM12878 rep2 GSM803387
H1 GSM803542
HepG2 GSM803499
SK-N-SH RA rep1 GSM803495
SK-N-SH RA rep2 GSM803495
mRNA-seq
Breast Luminal Epithelial Cells RM035 GSM543029
Breast Luminal Epithelial Cells RM080 GSM669620
Breast MyoEpithelial Cells RM035 GSM543031
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Experiment Sample GEO ID
Breast MyoEpithelial Cells RM080 GSM669621
CD4 Memory TC014 GSM669618
CD4 Naïve TC014 GSM669617
CD8 Naïve TC014 GSM669619
Fetal Brain HuFNSC01 GSM751274
Neurosphere Cultured Cells, Ganglionic Eminence Derived HuFNSC01 GSM751271
Neurosphere Cultured Cells, Ganglionic Eminence Derived HuFNSC02 GSM751273
H1ES GSM484408
TF ChIP-seq
(ENCODE)
RAD21 GM12878 Rep1 GSM803416
RAD21 SK-N-SH RA Rep1 GSM803497
YY1 GM12878 Rep GSM803406
YY1 SK-N-SH RA Rep GSM803498
NFKB GM12878 Rep1 GSM935478
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